These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients. Papuć E, Stelmasiak Z, Grieb P, Paweł G, Rejdak K. Neurosci Lett; 2010 Apr 19; 474(1):9-12. PubMed ID: 20193740 [Abstract] [Full Text] [Related]
5. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M. Arch Neurol; 2007 Aug 19; 64(8):1163-8. PubMed ID: 17698707 [Abstract] [Full Text] [Related]
6. Fatigue, mood and quality of life improve in MS patients after progressive resistance training. Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, Overgaard K, Ingemann-Hansen T. Mult Scler; 2010 Apr 19; 16(4):480-90. PubMed ID: 20194584 [Abstract] [Full Text] [Related]
7. A randomized crossover study of bee sting therapy for multiple sclerosis. Wesselius T, Heersema DJ, Mostert JP, Heerings M, Admiraal-Behloul F, Talebian A, van Buchem MA, De Keyser J. Neurology; 2005 Dec 13; 65(11):1764-8. PubMed ID: 16221950 [Abstract] [Full Text] [Related]
8. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Filippi M, Rocca MA, Colombo B, Falini A, Codella M, Scotti G, Comi G. Neuroimage; 2002 Mar 13; 15(3):559-67. PubMed ID: 11848698 [Abstract] [Full Text] [Related]
14. Rapid-onset central motor plasticity in multiple sclerosis. Zeller D, aufm Kampe K, Biller A, Stefan K, Gentner R, Schütz A, Bartsch A, Bendszus M, Toyka KV, Rieckmann P, Classen J. Neurology; 2010 Mar 02; 74(9):728-35. PubMed ID: 20194911 [Abstract] [Full Text] [Related]
15. Fatigued patients with multiple sclerosis have impaired central muscle activation. Andreasen AK, Jakobsen J, Petersen T, Andersen H. Mult Scler; 2009 Jul 02; 15(7):818-27. PubMed ID: 19465444 [Abstract] [Full Text] [Related]
17. The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D. Hawton A, Green C, Telford CJ, Wright DE, Zajicek JP. Mult Scler; 2012 Jun 02; 18(6):853-61. PubMed ID: 22108867 [Abstract] [Full Text] [Related]
20. Fatigue, depression and progression in multiple sclerosis. Koch M, Uyttenboogaart M, van Harten A, Heerings M, De Keyser J. Mult Scler; 2008 Jul 02; 14(6):815-22. PubMed ID: 18535019 [Abstract] [Full Text] [Related] Page: [Next] [New Search]